ArticlePharmacy world & science : PWS2005
Implementation of a pharmacist-led clinic for hypertensive patients in primary care--a pilot study.
Article in Pharmacy world & science : PWS, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 4 syntheses or guidelines pooled it, 53 citations in OpenAlex.
- Pharmacist services for non-hospitalised patients.The Cochrane database of systematic reviews · 2018Pooled it
- Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.The Cochrane database of systematic reviews · 2016Pooled it
- Team-based care and improved blood pressure control: a community guide systematic review.American journal of preventive medicine · 2014Pooled it
- Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.The Cochrane database of systematic reviews · 2010Pooled it
- Assessing pharmacy students' ability to accurately measure blood pressure using a blood pressure simulator arm.American journal of pharmaceutical education · 2013Trial
- Implementation of Clinical Pharmacy Services in Primary Health Care: A Scoping Review.Journal of evaluation in clinical practice · 2025Article
- Hypertension care: the knowledge and attitudes of the community pharmacists.Journal of pharmaceutical policy and practice · 2025Article
- Pharmacists delivering hypertension care services: a systematic review and meta-analysis of randomized controlled trials.Frontiers in cardiovascular medicine · 2025Article
- implementation of healthy heart ambassador to improve blood pressure control at community health centers in Texas.BMC health services research · 2024Article
- Effect of Medication Therapy Management by Pharmaceutical Care on Blood Pressure and Cardiovascular Risk in Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression.Pharmaceuticals (Basel, Switzerland) · 2023Review
- Use of Self-Measured Blood Pressure Monitoring to Improve Hypertension Equity.Current hypertension reports · 2022Review
- Self-Instruction Video Versus Face-to-Face Instruction of Pharmacy Students' Skills in Blood Pressure Measurement.Pharmacy (Basel, Switzerland) · 2020Article
- Hypertension care: sharing the burden with pharmacists.The British journal of general practice : the journal of the Royal College of General Practitioners · 2018Article
- Trends in the diagnosis and management of hypertension: repeated primary care survey in South West England.The British journal of general practice : the journal of the Royal College of General Practitioners · 2017Article
- Using scenarios to test the appropriateness of pharmacist prescribing in asthma management.Pharmacy practice · 2014Article
- Collaborative Cardiovascular Risk Reduction in Primary Care II (CCARP II): Implementation of a systematic case-finding process for patients with uncontrolled risk factors.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2013Article
- Dentists as oral physicians: the overlooked primary health care resource.The journal of primary prevention · 2013Article
- A comparison of the application of STOPP/START to patients' drug lists with and without clinical information.International journal of clinical pharmacy · 2013Article
- Article
- The impact of pharmaceutical care on patients with hypertension and their pharmacists.Pharmacy practice · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo implement a pharmacist-led Hypertension Management Clinic in one general medical practice. To evaluate the impact of the clinic on blood pressure (BP) control and prevention of coronary heart disease (CHD).
methodA total of 242 patients attended the pharmacist-led hypertension clinic over a 10-month period. Lifestyle and drug therapy alterations were implemented to achieve British Hypertension Society (BHS) target level BP. A sub-group of 160 patients were used to compare BP control in the clinic setting against that with the general practitioner (GP). Assessment was made of 10-year CHD risk in patients with no artherosclerotic disease. Patients with underlying artherosclerotic disease were prescribed statins, and antiplatelet drugs where indicated.
main outcome measuresChanges in numbers of hypertensive patients meeting the BHS target level BP. Changes in prescribing of antiplatelet agents and statins for primary and secondary prevention of artherosclerosis.
resultsIn 206 patients with established hypertension, the number achieving target level BPs increased from 74 (36%) pre-clinic to 174 (85%) post-clinic; P < 0.001 chi-squared test. After attending the clinic, for 5 months 74 patients (80%) achieved target level BP in the clinic compared with 27 (40%) with standard GP care; P < 0.001 chi-squared test. Of 188 patients assessed for primary prevention therapy, 126 (67%) required treatment with aspirin and 37 (20%) with a statin. Post-clinic 101 (80%) received aspirin compared with 17 (13%) pre-clinic and 34 (92%) received a statin in comparison with 4 (11%) pre-clinic; both P < 0.001 chi-squared test.A total of 52 (96%) of 54 patients received an antiplatelet agent for secondary prevention of artherosclerosis compared with 40 patients (74%) pre-clinic. Thirty six of 54 patients required a statin for secondary prevention. Thirty five patients (97%) received a statin compared with 23 (64%) pre-clinic; both P < 0.01 chi-squared test.
conclusionImplementation of a pharmacist-led clinic improved blood pressure control and appropriate prescribing of antiplatelet agents and statins for primary prevention of CHD and secondary prevention of artherosclerosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.